Neutralization of immune suppressive factors for the immunotherapy of cancer

The invention provides vectors comprising nucleic acid molecules that encode polypeptides capable of binding immune suppressive factors for the immunotherapy of cancer.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LATTIME EDMUND C, MONKEN CLAUDE E
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides vectors comprising nucleic acid molecules that encode polypeptides capable of binding immune suppressive factors for the immunotherapy of cancer.